A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects
Clinical trial NCT06161220 · COMPLETED
Trial details
- NCT number
- NCT06161220
- Sponsor
- Impax Laboratories, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2023-12-03
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.